Silverback Therapeutics Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Employees
-
92
- Latest Deal Type
-
Debt
- Financing Rounds
-
8
- Investments
-
1
Silverback Therapeutics General Information
Description
Developer of an immune technology platform designed to offer systemically delivered, tissue-targeted therapeutics. The company is focused on leveraging its technology platform to develop tissue targeted therapeutics, enabling users to treat cancer, chronic viral infections, and other serious diseases.
Contact Information
Website
www.silverbacktx.comCorporate Office
- 500 Fairview Avenue North
- Suite 600
- Seattle, WA 98109
- United States
Corporate Office
- 500 Fairview Avenue North
- Suite 600
- Seattle, WA 98109
- United States
Silverback Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Silverback Therapeutics Comparisons
Industry
Financing
Details
Silverback Therapeutics Competitors (48)
One of Silverback Therapeutics’s 48 competitors is CytomX Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Xenetic Biosciences | Corporation | Framingham, MA | ||||
| CSL Behring | Corporation | King Of Prussia, PA | ||||
| Cantex Pharmaceuticals | Formerly VC-backed | Weston, FL | ||||
| Oncorus | Formerly VC-backed | Andover, MA |
Silverback Therapeutics Signals
Silverback Therapeutics Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Silverback Therapeutics Acquisitions (1)
Silverback Therapeutics’s most recent deal was a Reverse Merger with ARS Pharmaceuticals for . The deal was made on 08-Nov-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ARS Pharmaceuticals | 08-Nov-2022 | Reverse Merger | Pharmaceuticals |
Silverback Therapeutics FAQs
-
When was Silverback Therapeutics founded?
Silverback Therapeutics was founded in 2016.
-
Where is Silverback Therapeutics headquartered?
Silverback Therapeutics is headquartered in Seattle, WA.
-
What is the size of Silverback Therapeutics?
Silverback Therapeutics has 92 total employees.
-
What industry is Silverback Therapeutics in?
Silverback Therapeutics’s primary industry is Biotechnology.
-
Is Silverback Therapeutics a private or public company?
Silverback Therapeutics is a Private company.
-
What is Silverback Therapeutics’s current revenue?
The current revenue for Silverback Therapeutics is .
-
How much funding has Silverback Therapeutics raised over time?
Silverback Therapeutics has raised $6M.
-
Who are Silverback Therapeutics’s investors?
Alexandria Real Estate Equities, Altamont Pharmaceutical Holdings, Boxer Capital, Bristol-Myers Squibb, and Celgene are 5 of 18 investors who have invested in Silverback Therapeutics.
-
Who are Silverback Therapeutics’s competitors?
CytomX Therapeutics, Xenetic Biosciences, CSL Behring, Cantex Pharmaceuticals, and Oncorus are some of the 48 competitors of Silverback Therapeutics.
-
When was Silverback Therapeutics acquired?
Silverback Therapeutics was acquired on 26-Mar-2025.
-
Who acquired Silverback Therapeutics?
Silverback Therapeutics was acquired by ARS Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process